Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Catalyst Pharm Inc (CPRX)

Catalyst Pharm Inc (CPRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 639,605
  • Shares Outstanding, K 102,996
  • Annual Sales, $ 500 K
  • Annual Income, $ -34,000 K
  • 60-Month Beta 2.38
  • Price/Sales 1,262.73
  • Price/Cash Flow N/A
  • Price/Book 9.96

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate 0.11
  • Number of Estimates 5
  • High Estimate 0.16
  • Low Estimate 0.08
  • Prior Year -0.08
  • Growth Rate Est. (year over year) +237.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.22 +18.85%
on 08/14/19
7.67 -19.04%
on 09/11/19
+0.91 (+17.17%)
since 08/13/19
3-Month
3.48 +78.45%
on 06/21/19
7.67 -19.04%
on 09/11/19
+2.36 (+61.30%)
since 06/13/19
52-Week
1.85 +235.68%
on 01/02/19
7.67 -19.04%
on 09/11/19
+3.01 (+94.06%)
since 09/13/18

Most Recent Stories

More News
Catalyst Pharmaceutical (CPRX) is a Great Momentum Stock: Should You Buy?

Does Catalyst Pharmaceutical (CPRX) have what it takes to be a top stock pick for momentum investors? Let's find out.

CPRX : 6.21 (+1.31%)
Implied Volatility Surging for Catalyst (CPRX) Stock Options

Investors need to pay close attention to Catalyst (CPRX) stock based on the movements in the options market lately.

CPRX : 6.21 (+1.31%)
Catalyst Pharmaceuticals, Inc. Determines Not to Proceed with Previously Announced Public Offering of Common Stock

Catalyst Pharmaceuticals, Inc. (NasdaqCM: CPRX) today announced that it will not conclude the offering of shares of its common stock announced on Wednesday, September 11, 2019. The Company believes that...

CPRX : 6.21 (+1.31%)
Catalyst Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock

Catalyst Pharmaceuticals, Inc. (NasdaqCM: CPRX) announced today that it has commenced an underwritten public offering of 8.0 million shares of its common stock. Catalyst also intends to grant the underwriters...

CPRX : 6.21 (+1.31%)
Investors Can Find Big Returns with this First Profit Screen

Investors Can Find Big Returns with this First Profit Screen

LIQT : 7.61 (-0.39%)
IRWD : 9.60 (-0.52%)
DBD : 13.37 (-0.52%)
CHRS : 20.20 (+1.30%)
CPRX : 6.21 (+1.31%)
Catalyst Pharmaceuticals (CPRX) Looks Good: Stock Adds 6% in Session

Catalyst Pharmaceuticals (CPRX) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.

LCI : 13.95 (+0.43%)
CPRX : 6.21 (+1.31%)
Catalyst Pharmaceuticals to Participate in the 14th Annual Citi Biotech Conference on September 4th, 2019

Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular...

CPRX : 6.21 (+1.31%)
Here's How to Find Top-Ranked Stocks Under $10 to Buy

Here's How to Find Top-Ranked Stocks Under $10 to Buy

NPTN : 6.72 (-0.59%)
MOBL : 7.52 (-0.92%)
DVAX : 4.46 (-5.91%)
EGO : 8.29 (-4.38%)
CPRX : 6.21 (+1.31%)
Top Ranked Momentum Stocks to Buy for August 19th

Top Ranked Momentum Stocks to Buy for August 19th

WW : 34.56 (-0.32%)
ECOR : 3.75 (+3.88%)
BLDR : 20.19 (+1.00%)
CPRX : 6.21 (+1.31%)
Will Catalyst Pharmaceuticals Continue to Surge Higher?

As of late, it has definitely been a great time to be an investor Catalyst Pharmaceuticals.

CPRX : 6.21 (+1.31%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade CPRX with:

Business Summary

CATALYST PHARMACEUTICAL PARTNERS, INC. is a biopharmaceutical company focused on the development and commercialization of prescription drugs for the treatment of addiction and obsessive compulsive disorders. The Company has obtained from Brookhaven National Laboratory an exclusive worldwide license for...

See More

Key Turning Points

2nd Resistance Point 7.16
1st Resistance Point 6.68
Last Price 6.21
1st Support Level 5.87
2nd Support Level 5.53

See More

52-Week High 7.67
Last Price 6.21
Fibonacci 61.8% 5.45
Fibonacci 50% 4.76
Fibonacci 38.2% 4.07
52-Week Low 1.85

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar